Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)
Clinical trial NCT06334419 · COMPLETED
Trial details
- NCT number
- NCT06334419
- Sponsor
- Craig Erickson
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2025-05-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.